Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WORMCON: Albendazole Efficacy for STH
NCT01087099Phase 4Completed
- Sponsor
- Ghent University
- Start
- Jan 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 4, open-label, single-arm trial of albendazole in ascariasis, hookworm infection and trichuriasis, sponsored by Ghent University. Primary endpoint: Efficacy of albendazole. Started Jan 2009; status: completed.
02
Drugs
albendazole
03
Conditions
ascariasishookworm infectiontrichuriasis
Beyond the preview
Go deeper on NCT01087099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087099.